mitomycin has been researched along with kanamycin a in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Hatsu, M; Hotta, K; Imai, S; Ishikawa, J; Mizuno, S; Phomsuwansiri, P; Zhu, CB | 1 |
Fujii, J; Taniguchi, H; Yoshida, S; Yoshimura, K | 1 |
TAGUCHI, A | 1 |
1 review(s) available for mitomycin and kanamycin a
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for mitomycin and kanamycin a
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
PCR inhibition assay for DNA-targeted antibiotics.
Topics: Actinomycetales; Anti-Bacterial Agents; Bacteriophage lambda; Base Sequence; Bleomycin; Culture Media, Conditioned; Cycloserine; DNA; DNA Damage; DNA Primers; DNA, Bacterial; DNA, Viral; Electrophoresis, Agar Gel; Ferrous Compounds; Kanamycin; Mitomycin; Molecular Sequence Data; Polymerase Chain Reaction; Templates, Genetic | 1995 |
Chemotherapy for enterohemorrhagic Escherichia coli O157:H infection in a mouse model.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Toxins; Colony Count, Microbial; Drug Synergism; Enterotoxins; Escherichia coli Infections; Escherichia coli O157; Feces; Fosfomycin; Injections, Intraperitoneal; Kanamycin; Male; Mice; Mice, Inbred ICR; Minocycline; Mitomycin; Norfloxacin; Shiga Toxin 2 | 1999 |
[BASIC STUDIES ON BONE TISSUE CULTURE AND THE EFFECT OF VARIOUS ANTIBIOTICS ON BONE GROWTH].
Topics: Anti-Bacterial Agents; Bone and Bones; Bone Development; Chick Embryo; Chloramphenicol; Culture Media; Erythromycin; Kanamycin; Mitomycin; Penicillins; Streptomycin; Tetracycline; Tissue Culture Techniques; Toxicology | 1963 |